How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S. 954 Affordable Insulin Now Act of 2023 and related administrative action
S. 954 Affordable Insulin Now Act of 2023 and related administrative action
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2024 · second_quarter · 2A
S. 954 Affordable Insulin Now Act of 2023 and related administrative action
Filing targets: Federal Trade Commission (FTC), SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2024 · second_quarter · Q2
Source: Senate LDA
Insulin for All Act of 2023 (H.R. 1485/S. 727); Affordable Insulin Now Act of 2023 (S. 954)
Prescription Pricing for the People Act of 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
Preserve Access to Affordable Generics and Biosimilars Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
Affordable Prescriptions for Patients Act of 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023
Insulin for All Act of 2023 (H.R. 1485/S. 727); Affordable Insulin Now Act of 2023 (S. 954)
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; Public Production Policies including the forthcoming Affordable Drug Manufacturing Act of 2023
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
Interagency Patent Coordination and Improvement Act of 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023
Insulin for All Act of 2023 (H.R. 1485/S. 727); Affordable Insulin Now Act of 2023 (S. 954)
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; Public Production Policies including the forthcoming Affordable Drug Manufacturing Act of 2023
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number); NDAA (Public Production Amendment 203); Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act (no bill number)
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Restoring the America Invents Act (S.2891)
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number); NDAA (Public Production Amendment 203); Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act (no bill number)
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
S. 954 Affordable Insulin Now Act of 2023 and related administrative action
Filing targets: Federal Trade Commission (FTC), SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2024 · first_quarter · Q1
The Affordable Insulin Now Act (SB 954); Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2023 or the INSULIN Act of 2023 (SB 1269)
Filing targets: SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2023 · fourth_quarter · Q4
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023
Filing targets: SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2023 · third_quarter · Q3
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; Public Production Policies including the forthcoming Affordable Drug Manufacturing Act of 2023
Filing targets: SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2023 · second_quarter · Q2
S. 954 Affordable Insulin for All Act of 2023; S. 727 Insulin for All Act of 2023; S. 150 Affordable Prescriptions for Patients Act of 2023; S. 148 Stop Stalling Act of 2023; S. 142 Preserve Access to Affordable Generics & Biosimilars Act; S. 113 Prescription Pricing for the People Act of 2023; S. 79 Interagency Patent Coordination and Improvement; S. 1139 Lower Drug Costs for Families Act of 2023; S. 1264 Smart Prices Act of 2023; ISLET Act; Supplies Act (Forthcoming Bill); S. 1283 Tax on Wall Street Speculation Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2023 · first_quarter · Q1
Insulin for All Act of 2023 (H.R. 1485/S. 727); Affordable Insulin Now Act of 2023 (S. 954)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2022 · fourth_quarter · Q4
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2022 · third_quarter · Q3
Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number); NDAA (Public Production Amendment 203); Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2022 · second_quarter · Q2
Restoring the America Invents Act (S.2891)
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2018 · third_quarter · RR
Advocacy on behalf of individuals with type 1 diabetes around the world.